Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Editing02:23

RNA Editing

8.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

10.4K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.4K
Experimental RNAi02:15

Experimental RNAi

6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

6.7K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.7K
RNA Interference01:23

RNA Interference

25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimised genome editing for precise DNA insertion and substitution using prime editors in zebrafish.

eLife·2026
Same author

Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the <i>HBG1/2</i> promoters.

Molecular therapy. Nucleic acids·2026
Same author

Detection of prediabetes and undiagnosed type 2 diabetes in underserved communities using community pharmacy point-of-care testing: A prospective feasibility study.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Aiolos and Eos drive distinct human TH17 functional states.

Cellular and molecular life sciences : CMLS·2026
Same author

A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader.

Nature communications·2026
Same author

Biophysical characterisation of mRNA structure and its impact on integrity analysis by liquid chromatography and capillary gel electrophoresis methods.

Journal of chromatography. A·2026

Related Experiment Video

Updated: May 15, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.7K

Modified pegRNAs mitigate scaffold-derived prime editing by-products.

Panagiotis Antoniou1, Louis Dacquay1,2, Hanna Mårtensson1

  • 1Genome Engineering, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

Nature Communications
|April 9, 2025
PubMed
Summary

Prime editing precision is improved by preventing reverse transcriptase (RT) from copying the prime editing guide RNA (pegRNA) scaffold. Modified pegRNAs with abasic spacers or 2’-O-methylation stop RT, reducing unwanted DNA by-products.

More Related Videos

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e
07:31

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Published on: February 17, 2023

1.1K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.6K

Related Experiment Videos

Last Updated: May 15, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.7K
Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e
07:31

Efficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e

Published on: February 17, 2023

1.1K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.6K

Area of Science:

  • Molecular Biology
  • Gene Editing Technologies

Background:

  • Prime editing (PE) enables precise genomic alterations using reverse transcriptase (RT) and a prime editing guide RNA (pegRNA).
  • A limitation of prime editing is the potential for RT to extend beyond the pegRNA template, incorporating scaffold sequences and reducing editing precision.

Purpose of the Study:

  • To develop and validate a method to prevent RT extension into the pegRNA scaffold.
  • To enhance the precision of prime editing by mitigating scaffold-derived by-products.

Main Methods:

  • Incorporation of an internal abasic spacer or 2'-O-methylation within the pegRNA sequence.
  • Utilizing modified pegRNAs with processive prime editors (PEs) like PE6d or PE** in various cell types.
  • Benchmarking the efficiency and precision of modified pegRNAs compared to standard pegRNAs.

Main Results:

  • Modified pegRNAs successfully terminated RT at the end of the template sequence.
  • Scaffold-derived by-products were significantly mitigated.
  • High prime editing precision was maintained across different cell types and with processive PEs.

Conclusions:

  • Internal abasic spacers or 2'-O-methylation in pegRNAs offer a simple and effective strategy to prevent RT extension.
  • This approach substantially improves prime editing precision by eliminating common by-products.
  • The developed method is compatible with existing prime editing systems and various cell types.